Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for MGTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 94.19M
March 31, 2026 81.45M
December 31, 2025 81.12M
September 30, 2025 80.48M
June 30, 2025 80.45M
March 31, 2025 79.42M
December 31, 2024 78.40M
September 30, 2024 77.70M
June 30, 2024 64.68M
March 31, 2024 64.30M
December 31, 2023 63.60M
September 30, 2023 59.60M
June 30, 2023 59.54M
March 31, 2023 48.69M
September 30, 2022 44.71M
June 30, 2022 44.71M
March 31, 2022 44.71M
December 31, 2021 44.55M
Date Value
September 30, 2021 44.32M
June 30, 2021 44.31M
March 31, 2021 44.28M
December 31, 2020 44.19M
September 30, 2020 38.41M
June 30, 2020 37.36M
March 31, 2020 36.82M
December 31, 2019 36.79M
September 30, 2019 36.57M
June 30, 2019 33.34M
March 31, 2019 33.34M
December 31, 2018 27.39M
September 30, 2018 27.18M
June 30, 2018 27.18M
March 31, 2018 27.93M
September 30, 2017 27.18M
June 30, 2017 27.93M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Xencor, Inc. 74.33M
UroGen Pharma Ltd. 48.87M
Ironwood Pharmaceuticals, Inc. 165.24M
Viking Therapeutics, Inc. 116.65M
IDEAYA Biosciences, Inc. 96.38M